Esparma GmbH
Records under this name other than patents Esparma GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Esparma GmbH
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,429,614 | Medicament containing an effector of the glutathione metabolism together with α-lipoic acid for treating diabetes mellitus Lapsed on the fee record Ended Sep 30, 2012 · From the USPTO record | Lapsed on the fee record | Ended Sep 30, 2012 | From the USPTO record |
| US 6,719,986 | Hyaluronate lyase used for promoting penetration in topical agents Lapsed on the fee record Ended Apr 13, 2012 · From the USPTO record | Lapsed on the fee record | Ended Apr 13, 2012 | From the USPTO record |
| US 6,689,349 | Skin protection agents containing a fragment mixture produced from hyaluronic acid by hydrolysis Lapsed on the fee record Ended Feb 10, 2012 · From the USPTO record | Lapsed on the fee record | Ended Feb 10, 2012 | From the USPTO record |
| US 6,518,300 | Treatment of lipid metabolic disorders using 5-(1,2-dithiolan-3-yl) valeric acid (&agr;-lipoic acid) or its physiologically compatible salts Lapsed on the fee record Ended Feb 11, 2011 · From the USPTO record | Lapsed on the fee record | Ended Feb 11, 2011 | From the USPTO record |
| US 6,413,950 | Pharmaceutical preparation containing dithranol Lapsed on the fee record Ended Jul 2, 2010 · From the USPTO record | Lapsed on the fee record | Ended Jul 2, 2010 | From the USPTO record |